Clinical trials: Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C, open to volunteers
- Condition Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
- Status Open to volunteers
Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Pharmacokinetics and Pharmacodynamics Study
The purpose of this study is to compare the pharmacokinetics and pharmacodynamics behavior of the two formulation of QLC7401 injection to further evaluate the effect of the production site change.
- Trial name
- NCT07074236
- Testing
- QLC7401 injection, RBD7022 injection
- Where
- China
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Qilu Pharmaceutical Co., Ltd.